4Front Ventures (OTCMKTS:FFNTF) versus IM Cannabis (NASDAQ:IMCC) Head to Head Contrast

IM Cannabis (NASDAQ:IMCC) and 4Front Ventures (OTCMKTS:FFNTF) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings and analyst recommendations.

Profitability

This table compares IM Cannabis and 4Front Ventures’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IM Cannabis	-27.65%	-585.96%	-39.96%
4Front Ventures	N/A	N/A	N/A

Earnings & Valuation

This table compares IM Cannabis and 4Front Ventures”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IM Cannabis	$39.17 million	0.02	-$8.10 million	($1.75)	-0.07
4Front Ventures	N/A	N/A	N/A	N/A	N/A

4Front Ventures has lower revenue, but higher earnings than IM Cannabis.

Analyst Recommendations

This is a summary of recent ratings for IM Cannabis and 4Front Ventures, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IM Cannabis	1	0	0	0	1.00
4Front Ventures	0	0	0	0	0.00

Given 4Front Ventures’ higher possible upside, analysts plainly believe 4Front Ventures is more favorable than IM Cannabis.

Institutional and Insider Ownership

7.7% of IM Cannabis shares are held by institutional investors. 5.9% of IM Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

About IM Cannabis

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

About 4Front Ventures

4Front Ventures Corp. owns and manages licensed cannabis facilities in state-licensed markets in the United States. The company operates through THC Cannabis and CBD Wellness segments. THC Cannabis segment engages in the cultivation, production, manufacturing, and distribution of THC cannabis products to owned dispensaries and third party retailers; and provision of ancillary services. This segment sells equipment, supplies, and intellectual property to cannabis producers; and leases real estate properties. The CBD Wellness segment sells non-THC hemp derived products. In addition, it operates dispensaries in the Massachusetts, Illinois, and Michigan primarily under the MISSION brand name. 4Front Ventures Corp. was founded in 2011 and is based in Phoenix, Arizona.